Why the study?
Does percutaneous transvenous mitral commissurotomy improve hemodynamics and provide sustained clinical benefits in patients with rheumatic mitral stenosis?
Population
4,850 patients with rheumatic mitral stenosis from a single center, mean age 27.2 +/- 11.2 years.
Design
Cohort
Follow-up
94 +/- 41 months (range, 12-166 months)
Authors
Loading...
PTMC yields high success and acute hemodynamic gains in rheumatic MS; extends observational data but leaves open randomized confirmation of sustained benefit.
Does percutaneous transvenous mitral commissurotomy improve hemodynamics and provide sustained clinical benefits in patients with rheumatic mitral stenosis?
Percutaneous transvenous mitral commissurotomy is highly effective and safe for rheumatic mitral stenosis, providing significant immediate hemodynamic improvement and sustained long-term benefits.
Arora et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: